AdvisorShares Investments LLC Has $500,000 Stock Position in Colgate-Palmolive (NYSE:CL)

AdvisorShares Investments LLC lessened its holdings in Colgate-Palmolive (NYSE:CL) by 4.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,232 shares of the company’s stock after selling 244 shares during the period. AdvisorShares Investments LLC’s holdings in Colgate-Palmolive were worth $500,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Angeles Wealth Management LLC lifted its holdings in shares of Colgate-Palmolive by 4.6% in the second quarter. Angeles Wealth Management LLC now owns 25,929 shares of the company’s stock valued at $2,516,000 after purchasing an additional 1,145 shares in the last quarter. MGO One Seven LLC raised its position in Colgate-Palmolive by 17.5% in the 2nd quarter. MGO One Seven LLC now owns 9,066 shares of the company’s stock valued at $880,000 after buying an additional 1,348 shares during the last quarter. Coldstream Capital Management Inc. lifted its stake in Colgate-Palmolive by 2.1% during the 2nd quarter. Coldstream Capital Management Inc. now owns 10,709 shares of the company’s stock valued at $1,039,000 after acquiring an additional 221 shares in the last quarter. Seaview Investment Managers LLC bought a new position in Colgate-Palmolive during the 2nd quarter valued at $425,000. Finally, Daiwa Securities Group Inc. boosted its holdings in Colgate-Palmolive by 9.6% during the 2nd quarter. Daiwa Securities Group Inc. now owns 92,341 shares of the company’s stock worth $8,961,000 after acquiring an additional 8,110 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In related news, EVP Gregory Malcolm sold 10,533 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the sale, the executive vice president now owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock worth $4,486,063 over the last ninety days. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $106.84 on Wednesday. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The stock has a market capitalization of $87.30 billion, a price-to-earnings ratio of 33.81, a price-to-earnings-growth ratio of 3.78 and a beta of 0.40. The stock’s 50-day simple moving average is $101.52 and its 200 day simple moving average is $94.88.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter last year, the business posted $0.77 earnings per share. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. Research analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.87%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CL shares. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Bank of America lifted their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Morgan Stanley boosted their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 10th. Nine equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $102.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.